Disclaimer: We may earn a commission if you make any purchase by clicking our links. Please see our detailed guide here.

Follow us on:

Google News

Microsoft Joins Hands With Adaptive Biotechnologies to Decode Human Immune System

Varun Kesari
Varun Kesari
Blogger | Youtuber | Music lover | Tech enthusiastic | Proud To be INDIAN

Join the Opinion Leaders Network

Join the Techgenyz Opinion Leaders Network today and become part of a vibrant community of change-makers. Together, we can create a brighter future by shaping opinions, driving conversations, and transforming ideas into reality.

Microsoft announced a partnership with Adaptive Biotechnologies – a biotechnology company – to detect cancers and other deadly diseases early. The based company uses artificial intelligence and machine learning technology from Microsoft to build individual disease diagnostics for patients starting from the blood test.

The partnership agreement is not just concentrated on the use of cloud computing solutions and the use of technology; in addition, Microsoft has invested on a large scale of the amount in Adaptive.

The goal of the partnership is to create a universal blood test that reads a patient’s immune system and detects the diseases which attack patients. This will help people to diagnose diseases in the early stages and get treated.

Adaptive Biotechnologies Partnership
Microsoft has taken advantage of the arrival of the new year to announce that it is expanding the partnership to expand the Antigen Map Project. The basis for its approach is is to sequence the immune system of 25,000 people and invite scientists and patient groups worldwide for the project.

“This announcement comes at a time of inflection in healthcare and biotechnology. We now have the technology to be able to do what we’ve been talking about for the past decade – develop a universal TCR antigen map that presents an opportunity to help patients at an unprecedented scale.” – Chad Robins, President, CEO and Co-Founder of Adaptive Biotechnologies.

The first five specific diseases initially developed include Type 1 diabetes, pancreatic cancer, ovarian cancer, celiac disease, and Lyme disease. These diseases play different roles in controlling or generating autoimmune diseases, cancer, and infections.

We are very excited and inspired by our collaboration with Adaptive Biotechnologies, which clearly increases our mission to use technologies based on artificial intelligence to transform health services and improve people’s lives around the world.

This partnership combines powerful sequencing and AI technology into a revolutionary new feature and represents the kind of deep collaboration that we live in.

– Peter Lee, corporate vice president of Microsoft’s AI division

The official bulletin about the project was also updated on the Microsoft website, explaining in detail how artificial intelligence to treat people.


Partner With Us

Digital advertising offers a way for your business to reach out and make much-needed connections with your audience in a meaningful way. Advertising on Techgenyz will help you build brand awareness, increase website traffic, generate qualified leads, and grow your business.

Power Your Business

Solutions you need to super charge your business and drive growth

More from this topic